- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03643679
Tobacco Cessation for Sexual Minorities
There is a growing body of evidence revealing disproportionately higher rates of tobacco use among sexual and gender minority (SGM) individuals, compared to their heterosexual peers. These disparities have led organizations to support the inclusion of SGM in all local, state, and national tobacco prevention and control activities. In an attempt to leverage the online milieu for health-related interventions, mobile apps have been created to support tobacco cessation. However, evidence-based apps promoted by the National Cancer Institute are unpopular, remain poorly supported, and were not studied for use by SGM persons. Commercial apps, on the other hand, have been downloaded millions of times, contain many valuable features, and enjoy better infrastructure. Unfortunately, they are not evidence-based and have not been rigorously tested.
The University of Pittsburgh (Pitt) is currently conducting a randomized controlled trial to assess the feasibility and efficacy of using the Kwit tobacco cessation app with patients at UPMC Montefiore and Presbyterian hospitals (PI: Chu). It is a pragmatic clinical trial applying a patient-centered outcomes framework to ensure that-rather than focusing only on successful cessation-the study includes measurements for quality of life, mobility, and social interactions. We propose to extend the study to underrepresented SGM young adults.
Survey measures will be adapted as needed to address issues specific to the SGM population.
Studieoversigt
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Forenede Stater, 15213
- University of Pittsburgh
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age 18-30
- Self-identified as a sexual minority (gay, lesbian, bisexual)
- Smokers interested in cessation (>1 cigarettes/day over the past 30 days)
- Must own an Apple or Android based smartphone.
Exclusion Criteria:
- Already receiving pharmacological and/or behavioral intervention or counseling for smoking cessation
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Kwit smartphone app
This arm will receive the Kwit smartphone app.
|
The Kwit smartphone app combines several popular features of tobacco cessation apps, including game-like features (e.g., unlocking achievement milestones for completing cessation-related tasks), useful statistics (e.g., money saved), and an ability to share progress with friends.
Users can actively engage with the app to track cravings or view progress, such as life expectancy gained.
A passive component notifies users when milestones have been achieved, e.g., when blood no longer contains nicotine.
Motivational messages can be actively requested at any time; they can also appear unsolicited, as when the user logs cravings.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Helpfulness, frequency of use, and ease of use of the intervention smartphone app
Tidsramme: 1-month and 3-month
|
Assessment of feasibility: Two follow-up surveys will be administered: the first, 1-month after recruitment,and the second, 3 months after recruitment. Surveys will be administered in-person. Specific questions will be asked to rate the Kwit smartphone application's feasibility, based on a combination of helpfulness, frequency of use, and ease of use. Frustrations and helpful aspects of the application will be assesses qualitatively.
Each of these responses (Q1-3) will be combined to report a single overall feasibility value. Qualitative data (Q4) will be used to modify scores as needed. |
1-month and 3-month
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Cessation (self-report)
Tidsramme: 1-month and 3-month
|
Descriptive statistics will be used to assess cessation outcomes. The information will be obtained via two follow-up surveys (1 month and 3 months after recruitment), with specific questions pertaining to the level of participant smoking as well as their confidence levels on maintaining cessation.
The overall assessment of cessation will be primarily based on the 7-day item. |
1-month and 3-month
|
|
Cessation (bio-chemical)
Tidsramme: 1-month and 3-month
|
Cessation will also be verified by a breath analysis monitor.
The information will be obtained during each follow-up.
Biochemical verification will be based on a 10 COppm cutoff to determine whether or not the participant has successfully quit tobacco.
|
1-month and 3-month
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- PRO18050656
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kwit smartphone app
-
Paris Nanterre UniversityAfsluttet
-
Hypnalgesics, LLCTufts UniversityAfsluttetTandlægeangst | Opioidbrug | Stofbrug | Dental smerteForenede Stater
-
University of California, San FranciscoConquer Cancer FoundationAfsluttetProstatakræft | Metastatisk prostatakræft | Metastatisk kastrationsresistent prostatakræftForenede Stater
-
Barbara Ann Karmanos Cancer InstituteAfsluttetKræft | Finansiel toksicitet | SpørgsmålslisteForenede Stater
-
Medical University of ViennaAktiv, ikke rekrutterende
-
Chang Gung UniversityChang Gung Memorial HospitalRekruttering
-
The University of Hong KongIkke rekrutterer endnuDigital sundhed | Knæsmerter/slidgigtHong Kong
-
Insel Gruppe AG, University Hospital BernUniversity of BernRekrutteringFedme hos børn | Teenagers fedme | Fedme | Ikke-smitsom sygdom | Livsstil | Opførsel, sundhed | Adfærd, SpisningSchweiz
-
University of Sao PauloIkke rekrutterer endnuFødselsdepression
-
Emory UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health...AfsluttetHIV-infektionerForenede Stater